State of Wyoming’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,209
Closed -$51.7K 1989
2025
Q2
$51.7K Buy
+8,209
New +$54.4K 0.01% 1556
2023
Q2
Sell
-3,304
Closed -$22.9K 1715
2023
Q1
$22.9K Buy
+3,304
New +$30.4K 0.01% 1395
2022
Q3
Sell
-4
Closed 1802
2022
Q2
$0 Sell
4
-798
-100% -$41.3K ﹤0.01% 2059
2022
Q1
$58K Buy
802
+796
+13,267% +$71K 0.03% 973
2021
Q4
$1K Sell
6
-2
-25% -$344 ﹤0.01% 1818
2021
Q3
$2K Sell
8
-5
-38% -$1.1K ﹤0.01% 1158
2021
Q2
$3K Buy
13
+6
+86% +$1.1K ﹤0.01% 1098
2021
Q1
$1K Buy
+7
New +$1.4K ﹤0.01% 492

Other funds holding NVAX

State of Wyoming's NVAX Position: Q3 2025 in Review

State of Wyoming sold out of Novavax (NVAX) in Q3 2025, closing a stake of 8,209 shares — an estimated $51.7K sold.

State of Wyoming first reported a position in NVAX in Q1 2021 and held it in 8 quarters. The position peaked at $58K in Q1 2022. 249 funds tracked by Wall St. Rank hold NVAX as of Q3 2025.

  • State of Wyoming reported no remaining Novavax position as of Q3 2025 after selling out during the quarter.
  • State of Wyoming sold 8,209 Novavax shares in Q3 2025, an estimated $51.7K.
  • State of Wyoming first reported a position in Novavax in Q1 2021 and held it in 8 quarters.
  • State of Wyoming's Novavax position peaked at $58K in Q1 2022.
  • 249 funds tracked by Wall St. Rank held Novavax as of Q3 2025.

Based on State of Wyoming's 13F filing for Q3 2025, filed 4 Nov 2025.